Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:nebivolol
|
| gptkbp:ATCCode |
C07AB12
|
| gptkbp:CASNumber |
152520-56-4
|
| gptkbp:contraindication |
severe bradycardia
liver impairment |
| gptkbp:developedBy |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:drugClass |
beta blocker
|
| gptkbp:eliminationHalfLife |
10 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
nebivolol hydrochloride
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Bystolic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
fatigue bradycardia |
| gptkbp:usedFor |
hypertension
|
| gptkbp:bfsParent |
gptkb:Bystolic
|
| gptkbp:bfsLayer |
8
|